AngioDynamics to Participate in Upcoming Investor Conferences

LATHAM, N.Y.--(BUSINESS WIRE)--Jul. 28, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that its management team is scheduled to participate in the following upcoming investor conferences: 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference Monday, August 10, 2026 Canaccord Genuity's 46th Annual Growth Conference Presentation: Tuesday, August 11, 2026 from 3:30-3:55 PM ET A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com. About AngioDynamics, Inc. AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients. The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. For more information, visit www.angiodynamics.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260728796556/en/ Investors: Stephen Trowbridge Executive Vice President & CFO 518-795-1408 [email protected] Media: Saleem Cheeks Vice President, Communications 518-795-1174 [email protected] Source: AngioDynamics, Inc.